Practice guidelines for the emergency treatment of thrombotic microangiopathy

Scully, 2012, Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies, Br J Haematol, 158, 323, 10.1111/j.1365-2141.2012.09167.x Contreras, 2015, [Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group], Med Clin (Barc), 144, 331.e1, 10.1016/j.medcli.2014.09.013 Scully, 2017, Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies, J Thromb Haemost, 15, 312, 10.1111/jth.13571 Gordon, 2017, Thrombotic microangiopathy: a multidisciplinary team approach, Am J Kidney Dis, 70, 715, 10.1053/j.ajkd.2017.05.017 Vesely, 2003, ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients, Blood, 102, 60, 10.1182/blood-2003-01-0193 Bittencourt, 2015, Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, PLoS ONE, 10, e0131384, 10.1371/journal.pone.0131384 Pereira, 1995, Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange, Ann Hematol, 70, 319, 10.1007/BF01696619 Allford, 2003, Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias, Br J Haematol, 120, 556, 10.1046/j.1365-2141.2003.04049.x AGREE Next Steps Consortium, 2009 Guyatt, 2008, GRADE: An emerging consensus on rating quality of evidence and strength of recommendations, BMJ Clin Res Ed, 336, 924, 10.1136/bmj.39489.470347.AD Guyatt, 2006, Grading strength of recommendations and quality evidence in clinical guidelines: report from an American College of Chest Physicians Task Force, Chest, 129, 174, 10.1378/chest.129.1.174 Hazarika, 2012, Thrombotic thrombocytopenic purpura in a patient with hemoglobin E disease – the importance of timely examination of a blood film, Am J Hematol, 87, 996, 10.1002/ajh.23197 Burns, 2004, Morphologic diagnosis of thrombotic thrombocytopenic purpura, Am J Hematol, 75, 18, 10.1002/ajh.10450 Zini, 2012, ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes, Int J Lab Hematol, 34, 107, 10.1111/j.1751-553X.2011.01380.x Coppo, 2015, French Reference Center for Thrombotic Microangiopathies. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange, Hematology Am Soc Hematol Educ Program, 2015, 637, 10.1182/asheducation-2015.1.637 Dutt, 2015, A proposal: the need for thrombotic thrombocytopenic purpura specialist centres-providing better outcomes, Br J Haematol, 170, 737, 10.1111/bjh.13568 Bell, 1991, Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients, N Engl J Med, 325, 398, 10.1056/NEJM199108083250605 Coppo, 2010, Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience, PLoS ONE, 5, e10208, 10.1371/journal.pone.0010208 Loirat, 2011, Atypical hemolytic uremic syndrome, Orphanet J Rare Dis, 6, 60, 10.1186/1750-1172-6-60 Cataland, 2014, How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome, Blood, 123, 2478, 10.1182/blood-2013-11-516237 Scully, 2014, How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome, Br J Haematol, 164, 759, 10.1111/bjh.12718 Campistol, 2015, Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso, Nefrologia, 35, 421, 10.1016/j.nefro.2015.07.005 George, 2010, How I treat patients with thrombotic thrombocytopenic purpura: 2010, Blood, 116, 4060, 10.1182/blood-2010-07-271445 Coppo, 2003, High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome, Medicine (Baltimore), 82, 27, 10.1097/00005792-200301000-00003 Blombery, 2016, Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry, Intern Med J, 46, 71, 10.1111/imj.12935 Fujimura, 2010, Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998–2008, Intern Med, 49, 7, 10.2169/internalmedicine.49.2706 Dahlan, 2015, Primary and secondary thrombotic microangiopathy referred to a single plasma exchange center for suspected thrombotic thrombocytopenic purpura: 2000–2011, Am J Nephrol, 41, 429, 10.1159/000437001 Schwartz, 2016, Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue, J Clin Apher, 31, 149 De la Rubia, 2001, Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura, Br J Haematol, 114, 721, 10.1046/j.1365-2141.2001.02991.x Del Río-Garma, 2008, Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study, Br J Haematol, 143, 39, 10.1111/j.1365-2141.2008.07292.x Sayani, 2015, How I treat refractory thrombotic thrombocytopenic purpura, Blood, 125, 3860, 10.1182/blood-2014-11-551580 Balduini, 2010, High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study, Ann Hematol, 89, 591, 10.1007/s00277-009-0877-5 Lozano, 2005, Platelet transfusion in thrombotic thrombocytopenic purpura: between Scylla and Charybdis, Transfusion, 45, 1984, 10.1111/j.1537-2995.2005.00656.x Swisher, 2009, Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura, Transfusion, 49, 873, 10.1111/j.1537-2995.2008.02082.x Thachil, 2010, The myths about platelet transfusions in immune-mediated thrombocytopenias, Br J Haematol, 150, 494 Benhamou, 2015, Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center, Am J Hematol, 90, E127, 10.1002/ajh.23997 Zhou, 2015, Outcomes of platelet transfusion in patients with thrombotic thrombocytopenic purpura: a retrospective case series study, Ann Hematol, 94, 467, 10.1007/s00277-014-2223-9 Otrock, 2015, Platelet transfusion in thrombotic thrombocytopenic purpura, Vox Sang, 109, 168, 10.1111/vox.12274